Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.

Highest usefulness score first. Studies without a score come last.

  1. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Archives of neurology 2003-10-01 How common it is

    The development of MCI is associated with measurements of cognition and depression, racial and constitutional factors, and cerebrovascular disease.

    Why it matters

    In the Cardiovascular Health Study cohort, mild cognitive impairment was associated with being African American, low education, low cognitive test scores, cortical atrophy, MRI-identified infarcts and depression measures. The amnestic (memory) type of MCI was linked to MRI-identified infarcts, the APOE epsilon4 allele and low Mini-Mental State scores, and the authors describe early cognitive deficits as common to both types. These are associations reported without effect sizes; the study does not show that any factor causes MCI, and it tests no treatment.

  2. Differences between caregivers and noncaregivers in psychological health and physical health: a meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Psychology and aging 2003-06-01 Caregiving

    Providing care for a frail older adult has been described as a stressful experience that may erode psychological well-being and physical health of caregivers.

    Why it matters

    Pooling 84 articles, this 2003 meta-analysis found caregivers of frail older adults differed most from noncaregivers in depression (g = .58), stress (g = .55), self-efficacy (g = .54) and well-being (g = -.40). Physical health was worse than in noncaregivers by a statistically significant but small margin (g = .18). Gaps were larger for dementia caregivers than for mixed caregiver samples, and also varied with study quality, the caregiver's relationship to the person cared for, gender and age. These are group differences, not proof that caregiving caused them.

  3. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Journal of clinical epidemiology 2003-04-01 Treatments

    Preparations based on special extracts of the Ginkgo biloba tree are popular in various European countries.

    Why it matters

    In this 24-week trial of 214 elderly patients with dementia or age-associated memory impairment, Ginkgo biloba extract EGb 761 showed no significant difference from placebo on any outcome measure. Neither the dementia subgroup nor the memory impairment subgroup experienced significant benefit, so the results do not support using Ginkgo for these conditions.

  4. Assessing the older person: is the MNA a more appropriate nutritional assessment tool than the SGA?

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. The journal of nutrition, health & aging 2003-01-01 End-of-life care

    This study has shown the MNA to be a more appropriate nutrition assessment tool for older patients when compared to the SGA.

  5. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Journal of the American Geriatrics Society 2001-12-01 Treatments

    Twenty-four-week, randomized, multicenter, parallel-group, double-blind, placebo-controlled trial.

    Why it matters

    This 24-week randomized, double-blind, placebo-controlled trial tested donepezil in 208 nursing home patients with Alzheimer's disease, using the Neuropsychiatric Inventory-Nursing Home Version as the primary outcome. It examined a symptomatic treatment for people who already have the disease, not a cure or prevention.

  6. Purpose of study The authors determined short-term effects of a home environmental intervention on self-efficacy and upset in caregivers and daily function of dementia patients.

    Why it matters

    In this randomized controlled trial of 171 families, a home environmental intervention led to fewer declines in patients' instrumental activities of daily living and less decline in self-care and fewer behavior problems at 3 months, with some caregiver benefits in certain subgroups. The authors describe the effect as modest, and it addresses daily function and caregiver well-being rather than curing or preventing Alzheimer's disease.

  7. Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Lancet (London, England) 2000-08-01 Vascular contributions

    Scores for periventricular hyperintensities in this sample included all possible degrees of severity, but no participant scored more than 75% of maximum for deep white-matter hyperintensities.

  8. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Neurology 2000-03-01 Brain tissue and pathology

    The Honolulu-Asia Aging Study is a longitudinal study of Japanese-American men living in Hawaii.

    Why it matters

    This longitudinal study of 3,385 older Japanese-American men examined whether use of vitamin E and C supplements protects against later dementia and poor cognitive functioning. It tests a possible preventive association rather than a treatment or cure.

  9. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Neurology 2000-01-01 Caregiving

    Failure to consider vascular cognitive impairment without dementia underestimates the prevalence of impairment and the risk for adverse outcomes associated with vascular cognitive impairment.

    Why it matters

    In a Canadian study following 10,253 people aged 65 and over for 5 years, the most common form of vascular cognitive impairment among those aged 65 to 84 was memory and thinking trouble that fell short of dementia. People with any vascular cognitive impairment were more likely than unimpaired people to move into institutional care or die, and their death rate was similar to that of people with Alzheimer's disease. The authors conclude that leaving out milder, non-dementia cases underestimates how common impairment is and how much risk it carries. The study observed these links; it did not test any treatment or prevention.

  10. Caregiving as a Risk Factor for Mortality: The Caregiver Health Effects Study

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. JAMA 1999-12-15 Caregiving

    This prospective study followed 392 older spousal caregivers and 427 non-caregivers for an average of 4.5 years.

    Why it matters

    Caregivers who reported feeling mental or emotional strain from caregiving had a 63% higher adjusted mortality risk than non-caregivers. Caregivers who did not report strain showed no elevated mortality risk, so the danger was caregiving under strain rather than caregiving itself.

  11. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Neurology 1999-04-01 Brain scans and imaging

    During the period of longitudinal observation, which averaged 32.6 months, 27 of the 80 MCI patients became demented.

    Why it matters

    In this longitudinal study, hippocampal atrophy at baseline was associated with progression from mild cognitive impairment to Alzheimer's disease over an average of 32.6 months. It suggests MRI-based hippocampal volume measurement may help predict conversion to Alzheimer's disease in older patients with mild cognitive impairment.

  12. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Archives of general psychiatry 1998-09-01 Getting a diagnosis

    The acceleration of incidence rates for AD and dementia slows down with the increase in age, although we find no evidence of a rate decline.

    Why it matters

    This meta-analysis found that incident dementia and Alzheimer disease increase with age but the increase slows at older ages, and that women are at higher risk of developing Alzheimer disease than men. It describes risk patterns and does not report any treatment, cure, or prevention.

  13. Delirium risk factors in elderly hospitalized patients

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Journal of general internal medicine 1998-03-01 Risk factors

    Despite methodologic limitations, certain risk factors for delirium seem to be consistent and could help identify high-risk patients.

    Why it matters

    This review of 27 studies aimed to identify risk factors for delirium in hospitalized elderly patients. It is about delirium in hospital, not about treating, curing or preventing Alzheimer's disease.

  14. Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Neurology 1997-12-01 How common it is

    We estimated the remaining lifetime risks of developing Alzheimer's disease (AD) and dementia from all causes, based on data from longitudinal population studies.

    Why it matters

    In 2,611 cognitively intact adults followed for 20 years in the Framingham Study, a 65-year-old woman's remaining lifetime risk of any dementia was estimated at 19% (12% for Alzheimer's disease) and a 65-year-old man's at 10.9% (6.3% for Alzheimer's). The usual "cumulative incidence" calculation, which ignores the chance of dying of something else first, gave much higher figures in the same people (45% and 32.8% for dementia), so the authors conclude that real lifetime risk "is lower than the hypothetical risk estimated by a cumulative incidence." Risk was higher in women but changed little between ages 65 and 80.

  15. Predicting time to nursing home care and death in individuals with Alzheimer disease

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. JAMA 1997-03-01 Vascular contributions

    The prediction algorithms are a first but promising step toward providing specific prognoses to patients, families, and practitioners.

  16. Training the elderly on the ability factors of spatial orientation and inductive reasoning

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Psychology and aging 1986-09-01 Prevention trials

    We examined the effects of cognitive training with elderly participants from the Seattle Longitudinal Study.

  17. Brain Imaging Biomarkers and Cognitive Outcomes in a Multidomain Lifestyle Intervention: The POINTER Imaging Ancillary Study

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. JAMA Neurology 2026-06-01 Prevention and risk

    This study found that a high-intensity multidomain lifestyle intervention did not affect brain biomarker trajectories and was not associated with Aβ pathology, but older adults with specific at-risk brain characteristics, including lower baseline HC volume, showed a greater cognitive benefit of the structured intervention.

    Why it matters

    In this imaging study, a high-intensity multidomain lifestyle intervention did not affect brain biomarker trajectories and was not associated with amyloid pathology. However, older adults with lower baseline hippocampal volume showed greater cognitive benefit from the structured intervention than from the self-guided one.

  18. Smoking Cessation, Weight Change, and Risk of Dementia: A Prospective Cohort Study

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. Neurology 2026-05-20 Prevention and risk

    Smoking cessation was associated with a sustained lower dementia risk and slower cognitive decline, comparable to never smokers and those without short-term risk increase.

    Why it matters

    In this long-term study, people who quit smoking had a lower risk of dementia than those who kept smoking, similar to the risk seen in people who had never smoked. The benefit appeared mostly in those who gained little or no weight after quitting, while quitting with more than 10 kg of weight gain showed no statistically significant link.

  19. Risk factors for early-onset and late-onset dementia: a prospective cohort study

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. The lancet. Healthy longevity 2026-04-02 Prevention and risk

    Female participants had a lower hazard of early-onset dementia compared with males (HR 0·70 [95% CI 0·61-0·80]).

    Why it matters

    This cohort found that diabetes, depression, smoking, obesity, physical inactivity, and alcohol overconsumption were each linked to a higher risk of early-onset dementia, while high blood pressure and high cholesterol were not statistically significant. The authors say this highlights modifiable risk factors as targets for primary prevention research.

  20. Digital Reminiscence for Predeath Grief Among Family Caregivers of Patients With Dementia: A Pilot Randomized Clinical Trial

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. JAMA Network Open 2026-04-01 Caregiving

    This pilot randomized clinical trial demonstrated the feasibility, acceptability, and preliminary efficacy of LMH-4-DCP in reducing caregiver grief, with improvements in caregiver-care recipient relationship quality.

    Why it matters

    This pilot trial of 68 caregivers found that a digital reminiscence intervention reduced predeath grief, though the improvement in relationship quality was not significant. The authors say these preliminary findings should inform a future, definitive efficacy trial.

  21. Frequent in dementia, deadliest without it: delirium and mortality in hospitalised older adults

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. Age and Ageing 2026-03-20 Clinical safety

    Among 2556 patients (mean age 79 ± 9 years; 56% women), delirium occurred in 957 (37%).

    Why it matters

    In this cohort of 2556 hospitalized older adults, delirium occurred in 37% and was associated with higher 90-day mortality, with the relative association strongest in those with no baseline dementia. The authors say the results provide a rationale for intervention trials to determine whether delirium prevention and management can reduce mortality, particularly among patients without known dementia.

  22. Resistance training and subcortical vascular cognitive impairment: A 12-month randomized trial

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. Alzheimer's & Dementia 2026 Treatments

    PRT may have a small beneficial effect on cognitive function in SVCI.

    Why it matters

    In this 12-month randomized trial of 91 adults with subcortical vascular cognitive impairment, progressive resistance training significantly improved cognitive scores compared with balance and tone exercises, and also reduced C-reactive protein. The effect was small and was seen in females but not males, so it suggests a possible modest benefit rather than a cure or prevention.

  23. Hearing Loss, Brain Structure, Cognition, and Dementia Risk in the Framingham Heart Study

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. JAMA Network Open 2025-11-05 Prevention and risk

    Sample 1 included 1656 participants (mean [range] age, 58.1 [29.7-85.6] years; 903 female [54.5%]), and sample 2 included 935 participants (mean [range] age, 67.6 [60.0-85.6] years; 518 female [55.4%]).

    Why it matters

    This cohort study found that midlife hearing loss was linked to smaller brain volumes, faster decline in executive function and higher dementia risk over 15 years, especially in people with at least one apolipoprotein E ε4 allele. It suggests hearing loss may be an early marker of brain aging and dementia risk.

  24. International Menopause Society (IMS) recommendations and key messages on women’s midlife health and menopause

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. Climacteric 2025-11-02 Risk factors

    Overall, 342 recommendations (285 supported by research data and 57 good practice points) and 40 key messages have been formulated.

    Why it matters

    These are recommendations and key messages on women's midlife health and menopause based on available evidence. The text does not address treating, curing, or preventing Alzheimer's disease.

  25. Social isolation and cognitive decline in older adults: a longitudinal study across 24 countries

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. BMC Geriatrics 2025-10-14 Risk factors

    Social isolation was significantly associated with reduced cognitive ability (pooled effect = -0.07, 95% CI = -0.08, -0.05), with consistently negative effects across memory, orientation, and executive ability.

    Why it matters

    This longitudinal study across 24 countries found that social isolation was associated with reduced cognitive ability in memory, orientation, and executive function, with stronger effects in the oldest-old, women, and those with lower socioeconomic status. It calls for cross-national interventions to strengthen social support and participation, but it does not test whether such interventions prevent or cure Alzheimer's disease.

From across this topic

10 of the 7,967 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

Other topics